Why the Exposure Metric and the Clock Both Matter
A drug concentration has no stand-alone meaning. Its interpretation depends on which exposure feature is relevant to the clinical question and when the sample was taken relative to dosing. A concentration taken just before a dose may be useful as a trough; the same number taken shortly after a dose may not be. Likewise, a peak target cannot be applied to an AUC estimate, and an AUC target cannot be applied to one concentration.
The cases below focus on a disciplined sequence: identify the intended metric, check the dosing and sampling record, decide whether the result is comparable with the target, and limit the conclusion to what the measurement supports. The targets and drugs are hypothetical. In practice, the applicable target, sampling protocol, assay, and clinical context must be established for the specific drug and indication.
A Case-Interpretation Sequence
Start with the target rather than with the reported number. A target such as “5–10 mg/L” is incomplete unless it is clear whether it applies to a trough, a timed post-dose peak, or another specified sample. For AUC, the interval and units matter: an AUC over 24 hours is not interchangeable with an AUC over 12 hours.
Next, reconstruct the exposure conditions. Confirm the dose, dosing interval, route, infusion duration when relevant, time of the last dose, sample collection time, and timing of any subsequent dose. Check whether the regimen was stable long enough for the intended interpretation, whether doses were taken as scheduled, and whether there were interruptions or unusual events. These details do not guarantee that a result is representative, but missing or contradictory details can make it uninterpretable.
Is the clinical question about a pre-dose concentration, a protocol-timed post-dose concentration, or integrated exposure over an interval?
Relate sample collection to actual dosing, not merely to the planned schedule. Check steady-state or other conditions required by the target.
Compare the measured or estimated value with a target defined for the same metric, time convention, interval, and units.
State whether the value is within the target and what it suggests. Also state what it cannot establish, such as the full concentration-time profile or the cause of a clinical outcome.
Worked Cases
Worked Example: A Near-Pre-Dose Trough
A hypothetical oral drug is administered every 12 hours. Its locally specified monitoring target is a steady-state trough of 5.0–10.0 mg/L, collected immediately before a dose. A patient has taken the same regimen for six days, reports no missed doses, and has no recent dose changes. The recorded sample time is 11 hours 42 minutes after the prior dose; the next dose was scheduled for 12 hours after that dose. The assay result is 4.2 mg/L. What can be concluded?
Metric and timing. The intended metric is a trough. The sample was collected 18 minutes before the scheduled next dose, so it is close to, but not exactly at, the target’s stated pre-dose time. The documented regimen and dosing history support a steady-state interpretation, assuming the history is accurate and there were no unreported interruptions.
Target comparison. Numerically, \(4.2\ \text{mg/L}\) is below the lower target boundary of \(5.0\ \text{mg/L}\). Because the sample is near the specified time, it is reasonable to describe the result as a near-trough below the stated trough range. The 18-minute difference should be reported rather than silently treated as no difference.
Interpretation and limits. This result supports concern that the pre-dose concentration may be below the intended range under the recorded conditions. It does not determine the AUC, the peak, or concentrations at every point in the interval. It also does not establish why the result is low or, by itself, dictate a dose change. The size of any timing effect depends on the drug’s concentration-time profile; without a suitable model or protocol specifying a timing correction, an exact corrected trough cannot be calculated from these facts alone.
Worked Example: A Protocol-Timed Peak
A hypothetical intravenous drug is infused over one hour. The monitoring protocol defines its peak sample as a sample collected one hour after the infusion ends, and gives a peak target of 20–30 mg/L under that protocol. The infusion began at 08:00 and ended at 09:00. A sample collected at 10:00 gives 32 mg/L. The dose was given as planned, and the sample was not drawn from the infusion line. Interpret the result.
Metric and timing. The requested metric is the protocol-defined peak, not a sample collected at the end of infusion. One hour after the 09:00 end time is 10:00, so the recorded sample matches the protocol time. The stated collection site also reduces concern that the sample was directly contaminated by drug in the infusion line, though it cannot rule out every pre-analytical or analytical issue.
Target comparison. The result is \(32\ \text{mg/L}\), which exceeds the upper target boundary:
Interpretation and limits. Under the stated protocol and conditions, the measured peak is above the target range. The conclusion is about this timed peak measurement; it is not proof that the AUC is above its target, nor does it describe every concentration between doses. The result alone does not establish a cause or determine a dose adjustment. If the timing, infusion record, or assay reliability were uncertain, comparability would need to be reconsidered before acting on the numerical comparison.
Worked Example: Estimating and Interpreting a Dosing-Interval AUC
A hypothetical drug is given every 24 hours at a stable regimen. A monitoring protocol specifies a steady-state \(AUC_{0-24}\) target of 200–300 mg·h/L. Concentrations measured at the stated times after a dose are 8 mg/L at 0 hours, 18 mg/L at 4 hours, 14 mg/L at 8 hours, 10 mg/L at 12 hours, 8 mg/L at 16 hours, 7 mg/L at 20 hours, and 8 mg/L at 24 hours. Assume the sampling and assay results are valid and the 24-hour value is consistent with the next interval’s pre-dose concentration. Estimate \(AUC_{0-24}\) by the linear trapezoidal rule and compare it with the target.
Justification of the calculation. Between two adjacent measurements, the linear trapezoidal rule approximates the concentration-time curve by a straight line. For concentrations \(C_i\) and \(C_{i+1}\) separated by \(\Delta t_i\), that segment’s area is the average endpoint concentration multiplied by the time:
This is the area of a trapezoid with parallel sides \(C_i\) and \(C_{i+1}\). Adding the segment areas gives the estimated AUC over the full interval. Here each interval is 4 hours:
Target comparison. The estimated \(AUC_{0-24}\) is \(260\ \text{mg·h/L}\), which lies within the specified range of 200–300 mg·h/L. The result is an estimate from the measured profile, not an exact value. Its reliability depends on whether the measurements represent the interval adequately and on the validity of the assumed trapezoidal approximation between samples. The result supports an in-range interval AUC under the stated conditions; it does not imply that every concentration is within a separate concentration target or that clinical response is assured.
Why the Comparison Depends on the Metric
A trough, a timed peak, and an AUC answer different questions. A trough characterizes concentration near a specified dosing boundary; a protocol-timed peak describes concentration at one post-dose time; an AUC summarizes exposure over an interval. None can be substituted for another without a validated relationship appropriate to the drug and dosing conditions.
| Metric | What it summarizes | What to verify before target comparison | Important limitation |
|---|---|---|---|
| Trough | Concentration at a defined near-end-of-interval time | Time since last dose, time to next dose, regimen, and trough target definition | One value does not determine the full profile or interval AUC |
| Peak | Concentration at a specified post-dose or post-infusion time | Dose and infusion times, sample timing convention, and peak target definition | A protocol-timed peak is not necessarily the absolute maximum concentration |
| AUC | Integrated concentration over a stated interval | Interval, sampling or estimation method, units, and conditions for the target | An estimate depends on the method and data; it does not show the entire profile by itself |
The main alternative is not “use whichever number is available.” It is to obtain or estimate the metric that answers the clinical question, using a method validated for that purpose. When direct timed sampling is impractical, limited-sampling or model-based approaches may be considered if their assumptions and validation apply. Those approaches can add estimation uncertainty; they do not make timing, dose history, or target definition irrelevant. A single concentration may be useful for a targeted question, but it should not be relabelled as an AUC or peak simply because a corresponding target is available.
Diagnostics, Failure Modes, and Limits
Before interpreting a value as a genuine exposure signal, look for contradictions: a sample timestamp that precedes the recorded dose, a concentration labelled “trough” collected well after dosing, an infusion duration inconsistent with the peak protocol, or an AUC reported for a different interval than the target. Such discrepancies call for clarification or qualification, not an unsupported numerical adjustment.
The interpretation also relies on conditions that may be uncertain. A recorded dosing history may not capture missed or delayed doses. A result can be affected by sample handling, assay uncertainty, contamination, or within-patient variability. Stability of regimen and steady state must be judged in relation to the drug and protocol, rather than inferred from the mere presence of a concentration measurement. If these conditions are not established, say so explicitly and avoid presenting the target comparison as definitive.
Even a well-timed, analytically valid value has a limited scope. It is evidence about a measured or estimated exposure feature under the conditions of that assessment. It does not, alone, establish toxicity, efficacy, adherence, the cause of a clinical change, or the best dosing action. Those conclusions require the relevant clinical information and, where appropriate, additional measurements or a validated model.
Check Your Understanding
For each situation, identify the defensible interpretation. The solutions are included after the questions.
- A hypothetical 12-hour regimen has a trough target of 4–8 mg/L. A sample of 3.5 mg/L was collected exactly 30 minutes after the scheduled next dose. Can it be directly interpreted as a pre-dose trough? Explain.
- A protocol defines a peak as a sample 90 minutes after an infusion ends. The infusion ends at 14:00 and the sample is collected at 15:30. What is the timing difference from the protocol?
- A hypothetical 24-hour AUC target is 150–250 mg·h/L. A valid estimate is 145 mg·h/L. State the comparison and one conclusion that would go beyond the measurement.
- Why is it invalid to compare a 12-hour AUC directly with a target explicitly defined for \(AUC_{0-24}\), even if both are reported in mg·h/L?
Solutions. (1) No. The sample was collected after the dose, not immediately before it, so it is not a pre-dose trough under the stated definition. Its value should not be directly compared with the trough target as though collection occurred before dosing; interpretation requires the actual dosing and sampling record and, if needed, a protocol-appropriate approach. (2) The protocol time is 90 minutes after 14:00, which is 15:30. The sample matches the specified time, assuming the infusion-end and collection times are accurate. (3) \(145\ \text{mg·h/L}<150\ \text{mg·h/L}\), so the estimate is just below the specified range. It does not, by itself, establish toxicity, lack of efficacy, or the appropriate dose change. (4) The two values summarize exposure over different intervals. The 12-hour AUC does not represent the full 24-hour interval, so matching units alone does not make the quantities comparable; use an estimate and target defined for the same interval and conditions.